Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I)

H. Madry, G. Kaul, M. Cucchiarini, U. Stein, D. Zurakowski, K. Remberger, M. D. Menger, D. Kohn, Stephen Trippel

Research output: Contribution to journalArticle

164 Citations (Scopus)

Abstract

Traumatic articular cartilage lesions have a limited capacity to heal. We tested the hypothesis that overexpression of a human insulin-like growth factor I (IGF-I) cDNA by transplanted articular chondrocytes enhances the repair of full-thickness (osteochondral) cartilage defects in vivo. Lapine articular chondrocytes were transfected with expression plasmid vectors containing the cDNA for the Escherichia coli lacZ gene or the human IGF-I gene and were encapsulated in alginate. The expression patterns of the transgenes in these implants were monitored in vitro for 36 days. Transfected allogeneic chondrocytes in alginate were transplanted into osteochondral defects in the trochlear groove of rabbits. At three and 14 weeks, the quality of articular cartilage repair was evaluated qualitatively and quantitatively. In vitro, IGF-I secretion by implants constructed from IGF-I-transfected chondrocytes and alginate was 123.2±22.3 ng/107 cells/24 h at day 4 post transfection and remained elevated at day 36, the longest time point evaluated. In vivo, transplantation of IGF-I implants improved articular cartilage repair and accelerated the formation of the subchondral bone at both time points compared to lacZ implants. The data indicate that allogeneic chondrocytes, transfected by a nonviral method and cultured in alginate, are able to secrete biologically relevant amounts of IGF-I over a prolonged period of time in vitro. The data further demonstrate that implantation of these composites into deep articular cartilage defects is sufficient to augment cartilage defect repair in vivo. These results suggest that therapeutic growth factor gene delivery using encapsulated and transplanted genetically modified chondrocytes may be applicable to sites of focal articular cartilage damage.

Original languageEnglish
Pages (from-to)1171-1179
Number of pages9
JournalGene Therapy
Volume12
Issue number15
DOIs
StatePublished - Aug 2005

Fingerprint

Articular Cartilage
Chondrocytes
Insulin-Like Growth Factor I
Cartilage
Complementary DNA
Joints
Lac Operon
Transgenes
Osteogenesis
Genes
Transfection
Intercellular Signaling Peptides and Proteins
Plasmids
Transplantation
Escherichia coli
Rabbits
alginic acid
In Vitro Techniques

Keywords

  • Alginate
  • Cartilage defects
  • Cell transplantation
  • Chondrocytes
  • Gene transfer
  • IGF-I

ASJC Scopus subject areas

  • Genetics

Cite this

Madry, H., Kaul, G., Cucchiarini, M., Stein, U., Zurakowski, D., Remberger, K., ... Trippel, S. (2005). Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Therapy, 12(15), 1171-1179. https://doi.org/10.1038/sj.gt.3302515

Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). / Madry, H.; Kaul, G.; Cucchiarini, M.; Stein, U.; Zurakowski, D.; Remberger, K.; Menger, M. D.; Kohn, D.; Trippel, Stephen.

In: Gene Therapy, Vol. 12, No. 15, 08.2005, p. 1171-1179.

Research output: Contribution to journalArticle

Madry, H, Kaul, G, Cucchiarini, M, Stein, U, Zurakowski, D, Remberger, K, Menger, MD, Kohn, D & Trippel, S 2005, 'Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I)', Gene Therapy, vol. 12, no. 15, pp. 1171-1179. https://doi.org/10.1038/sj.gt.3302515
Madry, H. ; Kaul, G. ; Cucchiarini, M. ; Stein, U. ; Zurakowski, D. ; Remberger, K. ; Menger, M. D. ; Kohn, D. ; Trippel, Stephen. / Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). In: Gene Therapy. 2005 ; Vol. 12, No. 15. pp. 1171-1179.
@article{a772255e5380412490bcb7533984aa73,
title = "Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I)",
abstract = "Traumatic articular cartilage lesions have a limited capacity to heal. We tested the hypothesis that overexpression of a human insulin-like growth factor I (IGF-I) cDNA by transplanted articular chondrocytes enhances the repair of full-thickness (osteochondral) cartilage defects in vivo. Lapine articular chondrocytes were transfected with expression plasmid vectors containing the cDNA for the Escherichia coli lacZ gene or the human IGF-I gene and were encapsulated in alginate. The expression patterns of the transgenes in these implants were monitored in vitro for 36 days. Transfected allogeneic chondrocytes in alginate were transplanted into osteochondral defects in the trochlear groove of rabbits. At three and 14 weeks, the quality of articular cartilage repair was evaluated qualitatively and quantitatively. In vitro, IGF-I secretion by implants constructed from IGF-I-transfected chondrocytes and alginate was 123.2±22.3 ng/107 cells/24 h at day 4 post transfection and remained elevated at day 36, the longest time point evaluated. In vivo, transplantation of IGF-I implants improved articular cartilage repair and accelerated the formation of the subchondral bone at both time points compared to lacZ implants. The data indicate that allogeneic chondrocytes, transfected by a nonviral method and cultured in alginate, are able to secrete biologically relevant amounts of IGF-I over a prolonged period of time in vitro. The data further demonstrate that implantation of these composites into deep articular cartilage defects is sufficient to augment cartilage defect repair in vivo. These results suggest that therapeutic growth factor gene delivery using encapsulated and transplanted genetically modified chondrocytes may be applicable to sites of focal articular cartilage damage.",
keywords = "Alginate, Cartilage defects, Cell transplantation, Chondrocytes, Gene transfer, IGF-I",
author = "H. Madry and G. Kaul and M. Cucchiarini and U. Stein and D. Zurakowski and K. Remberger and Menger, {M. D.} and D. Kohn and Stephen Trippel",
year = "2005",
month = "8",
doi = "10.1038/sj.gt.3302515",
language = "English",
volume = "12",
pages = "1171--1179",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "15",

}

TY - JOUR

T1 - Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I)

AU - Madry, H.

AU - Kaul, G.

AU - Cucchiarini, M.

AU - Stein, U.

AU - Zurakowski, D.

AU - Remberger, K.

AU - Menger, M. D.

AU - Kohn, D.

AU - Trippel, Stephen

PY - 2005/8

Y1 - 2005/8

N2 - Traumatic articular cartilage lesions have a limited capacity to heal. We tested the hypothesis that overexpression of a human insulin-like growth factor I (IGF-I) cDNA by transplanted articular chondrocytes enhances the repair of full-thickness (osteochondral) cartilage defects in vivo. Lapine articular chondrocytes were transfected with expression plasmid vectors containing the cDNA for the Escherichia coli lacZ gene or the human IGF-I gene and were encapsulated in alginate. The expression patterns of the transgenes in these implants were monitored in vitro for 36 days. Transfected allogeneic chondrocytes in alginate were transplanted into osteochondral defects in the trochlear groove of rabbits. At three and 14 weeks, the quality of articular cartilage repair was evaluated qualitatively and quantitatively. In vitro, IGF-I secretion by implants constructed from IGF-I-transfected chondrocytes and alginate was 123.2±22.3 ng/107 cells/24 h at day 4 post transfection and remained elevated at day 36, the longest time point evaluated. In vivo, transplantation of IGF-I implants improved articular cartilage repair and accelerated the formation of the subchondral bone at both time points compared to lacZ implants. The data indicate that allogeneic chondrocytes, transfected by a nonviral method and cultured in alginate, are able to secrete biologically relevant amounts of IGF-I over a prolonged period of time in vitro. The data further demonstrate that implantation of these composites into deep articular cartilage defects is sufficient to augment cartilage defect repair in vivo. These results suggest that therapeutic growth factor gene delivery using encapsulated and transplanted genetically modified chondrocytes may be applicable to sites of focal articular cartilage damage.

AB - Traumatic articular cartilage lesions have a limited capacity to heal. We tested the hypothesis that overexpression of a human insulin-like growth factor I (IGF-I) cDNA by transplanted articular chondrocytes enhances the repair of full-thickness (osteochondral) cartilage defects in vivo. Lapine articular chondrocytes were transfected with expression plasmid vectors containing the cDNA for the Escherichia coli lacZ gene or the human IGF-I gene and were encapsulated in alginate. The expression patterns of the transgenes in these implants were monitored in vitro for 36 days. Transfected allogeneic chondrocytes in alginate were transplanted into osteochondral defects in the trochlear groove of rabbits. At three and 14 weeks, the quality of articular cartilage repair was evaluated qualitatively and quantitatively. In vitro, IGF-I secretion by implants constructed from IGF-I-transfected chondrocytes and alginate was 123.2±22.3 ng/107 cells/24 h at day 4 post transfection and remained elevated at day 36, the longest time point evaluated. In vivo, transplantation of IGF-I implants improved articular cartilage repair and accelerated the formation of the subchondral bone at both time points compared to lacZ implants. The data indicate that allogeneic chondrocytes, transfected by a nonviral method and cultured in alginate, are able to secrete biologically relevant amounts of IGF-I over a prolonged period of time in vitro. The data further demonstrate that implantation of these composites into deep articular cartilage defects is sufficient to augment cartilage defect repair in vivo. These results suggest that therapeutic growth factor gene delivery using encapsulated and transplanted genetically modified chondrocytes may be applicable to sites of focal articular cartilage damage.

KW - Alginate

KW - Cartilage defects

KW - Cell transplantation

KW - Chondrocytes

KW - Gene transfer

KW - IGF-I

UR - http://www.scopus.com/inward/record.url?scp=23744467071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23744467071&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3302515

DO - 10.1038/sj.gt.3302515

M3 - Article

C2 - 15815701

AN - SCOPUS:23744467071

VL - 12

SP - 1171

EP - 1179

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 15

ER -